Abstract B184: HSP90 inhibitor STA-9090 potently suppresses heterogeneous KIT kinase-domain mutations responsible for gastrointestinal stromal tumor progression during imatinib therapy

Jonathan A. Fletcher, George D. Demetri, Rachel Donsky et al.|Molecular Cancer Therapeutics|2009

Cited by 3